Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 14, 2023
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives
Jay M Lee, Ciaran J McNamee, Eric Toloza, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 13, 2018
A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors
Kiri A Sandler, Fereidoun Abtin, Robert Suh, et al.
JAMA Oncology
|
January 11, 2024
Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Trudy C Wu, Elaine Luterstein, Beth K Neilsen, et al.
Future Oncology (London, England)
|
March 2, 2021
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
Pilar Garrido, Jean-Louis Pujol, Edward S Kim, et al.
Expert Review of Anticancer Therapy
|
October 20, 2007
Inflammation and lung carcinogenesis: applying findings in prevention and treatment
Katherine A Peebles, Jay M Lee, Jenny T Mao, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 15, 2014
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas
Anthony Y Lin, Svetlana Kotova, Jane Yanagawa, et al.
Journal of the American Heart Association
|
January 14, 2021
Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation
Veronica Dusi, Jeffrey Gornbein, Duc H Do, et al.
American Journal of Translational Research
|
March 21, 2020
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells
Mi-Heon Lee, Jane Yanagawa, Linh Tran, et al.
JTO Clinical and Research Reports
|
August 14, 2025
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC
Jay M Lee, Jean-Louis Pujol, Jun Zhang, et al.
International Trends in Immunity
|
September 30, 2014
CCL21 Chemokine Therapy for Lung Cancer
Sherven Sharma, Li Zhu, Minu K Srivastava, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 14, 2023
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives
Jay M Lee, Ciaran J McNamee, Eric Toloza, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 13, 2018
A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors
Kiri A Sandler, Fereidoun Abtin, Robert Suh, et al.
JAMA Oncology
|
January 11, 2024
Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial
Trudy C Wu, Elaine Luterstein, Beth K Neilsen, et al.
Future Oncology (London, England)
|
March 2, 2021
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
Pilar Garrido, Jean-Louis Pujol, Edward S Kim, et al.
Expert Review of Anticancer Therapy
|
October 20, 2007
Inflammation and lung carcinogenesis: applying findings in prevention and treatment
Katherine A Peebles, Jay M Lee, Jenny T Mao, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 15, 2014
Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas
Anthony Y Lin, Svetlana Kotova, Jane Yanagawa, et al.
Journal of the American Heart Association
|
January 14, 2021
Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation
Veronica Dusi, Jeffrey Gornbein, Duc H Do, et al.
American Journal of Translational Research
|
March 21, 2020
FRA1 contributes to MEK-ERK pathway-dependent PD-L1 upregulation by KRAS mutation in premalignant human bronchial epithelial cells
Mi-Heon Lee, Jane Yanagawa, Linh Tran, et al.
JTO Clinical and Research Reports
|
August 14, 2025
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB-IIIA NSCLC
Jay M Lee, Jean-Louis Pujol, Jun Zhang, et al.
International Trends in Immunity
|
September 30, 2014
CCL21 Chemokine Therapy for Lung Cancer
Sherven Sharma, Li Zhu, Minu K Srivastava, et al.
Page
of 10